OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
Yan Feng, Jaewon Lee, Liping Yang, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113503-113503
Open Access | Times Cited: 14

Showing 14 citing articles:

Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
Qian Chen, Zhen Yang, Haoyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 674-674
Open Access | Times Cited: 16

Advancements in antibody-drug conjugates as cancer therapeutics
Jung Yin Fong, Zhixin Phuna, D. Chong, et al.
Journal of the National Cancer Center (2025)
Open Access | Times Cited: 1

Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
Jun He, Xianghua Zeng, Chunmei Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6

B7-H3-Liquid Biopsy for the Characterization and Monitoring of the Dynamic Biology of Prostate Cancer
Yong Ju, Joshua Watson, Jasmine J. Wang, et al.
Drug Resistance Updates (2025), pp. 101207-101207
Closed Access

Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer
Ying Jiang, Zhiwen Qian, C Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010924-e010924
Open Access

The physiological limits of bispecific monoclonal antibody tissue targeting specificity
Armin Sepp, Felix Stader, Abdallah Derbalah, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access

Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics
Deyi Zhao, Zhe Li, Ding‐Kun Ji, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 803-803
Open Access | Times Cited: 3

The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer
Zhideng Yan, Zhihui Zhong, Chuanke Shi, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2

Benzyl Ammonium Carbamates Undergo Two‐Step Linker Cleavage and Improve the Properties of Antibody Conjugates
Xiaoyi Li, Nimit L. Patel, Joseph D. Kalen, et al.
Angewandte Chemie International Edition (2024)
Open Access | Times Cited: 2

Generation of B7H3 isoform regulated by ANXA2/NSUN2/YBX1 axis in human glioma
Yifen Shen, Chunfang Ma, Xiangxiang Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 1

Radiomic Features Based on Pyradiomics Predict CD276 Expression Associated with Breast Cancer Prognosis
Yong Li, Chunmei Chen, Weiwen Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37345-e37345
Open Access

Improving Targeted Delivery and Antitumor Efficacy of TRAIL through Fusion with a B7H3-Antagonistic Affibody
Xiaomeng Lu, Xinyu Zhan, Guozi Xia, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 284-294
Closed Access

Page 1

Scroll to top